November 16, 2017
Cynthia Prairie

Fresh off the successful enactment of a law limiting generic and off-brand prescription drug price increases, Vincent DeMarco, president of the Maryland Citizens’ Health Initiative, is pushing for greater limitations on name-brand drugs. His organization’s ideas, he says, are popular — and he has the numbers to show it, Samuel Manas writes in Maryland Matters.

  • Under the legislation proposed, the state would create a Prescription Drug Cost Review Commission, similar to the Health Services Cost Review Commission that sets rates for services at Maryland’s hospitals, writes Tim Curtis in the Daily Record. The proposal would also allow pharmacists to provide information to consumers about lower-cost alternatives and require drug companies to justify prices for new drugs as well as price increases for older drugs.
Last modified: November 16, 2017